Open AccessCommentary on the “Evidence- and Consensus-Based (S3) Guidelines for the Treatment of Actinic Keratosis” Published by the International League of Dermatological Societies in Cooperation with the European Dermatology Forum
Author(s) -
Thomas L. Diepgen,
Joachim Kresken,
Jean Krutmann,
Hans F. Merk,
Erik Senger,
Christian Surber,
RolfMarkus Szeimies
Publication year - 2018
Publication title -
skin pharmacology and physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.703
H-Index - 74
eISSN - 1660-5535
pISSN - 1660-5527
DOI - 10.1159/000486687
Subject(s) - guideline , actinic keratosis , dermatology , medicine , league , consensus conference , family medicine , pathology , physics , astronomy , basal cell
In 2015, the International League of Dermatological Societies and the European Dermatology Forum published a guideline for the treatment of actinic keratosis, which is classified as an evidence- and consensus-based S3 guideline. From the point of view of the GD Task Force "Licht.Hautkrebs.Prävention," an interdisciplinary expert panel of the Society for Dermopharmacy for the prevention and treatment of skin cancer, this guideline reveals strengths and weaknesses but, in summary, does not meet the claim for an evidence- and consensus-based S3 guideline.